Patients with cancer who have germline mutations overwhelmingly acknowledge the importance of informing relatives of their risks, but gaps in testing show the health care system has not adequately ...
The Brighterside of News on MSN
New AI tool predicts breast cancer recurrence faster
A new artificial intelligence tool may soon change how doctors understand breast cancer risk, offering faster answers and ...
SpudCell marks a milestone for synthetic biology, but it is not fully alive. It will, however, help scientists answer key ...
For decades, cancer carried an image of being an illness that arrived late in life. It was considered a disease of old age, ...
Although about 90 per cent of cancers are sporadic and can affect anyone regardless of genetics, experts say small, sustained ...
India is facing a growing burden of breast cancer, with projections indicating a significant rise in mortality in the coming decades. According to a new study published in The Lancet Oncology, global ...
A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...
Blood tests on the horizon, and under federal regulatory view, may be about to transform cancer care — and survival. The Food and Drug Administration has been evaluating a blood test called Galleri ...
No one looks forward to a colonoscopy, but for the millions of Americans who refuse screening, a simple blood test could help catch colon cancer. For the first time, the American Cancer Society ...
The American Cancer Society recently recommended that two blood tests can be an option for people who won't get a colonoscopy or do a stool test. No one looks forward to a colonoscopy, but for the ...
If you can’t prevent cancer, the best chances of treating or surviving it may come down to finding a tumor early when it hasn’t yet spread. A new test called Cancerguard offers to screen for more than ...
At least 12 of my colleagues boarded planes to the American Society of Clinical Oncology conference in Chicago last week to hear Charles Swanton of the Francis Crick Institute in London share results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results